TY  - RPRT
TI  - Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.
AU  - Linong Ji
AU  - Malik Benamar
AU  - Viswanathan Mohan
AU  - Laura Pletsch-Borba
AU  - Francesca Porcellati
AU  - Ni Wang
AU  - Hirotaka Watada
AU  - Rosangela R Rea
PY  - 2026
DO  - 10.1016/s2213-8587(26)00136-1
UR  - https://pubmed.ncbi.nlm.nih.gov/42594928/
ID  - 42594928
ER  -